Equine CA-125 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CA-125 antibodies pairs and antigen for animal health (animal Equine/Horse ovarian, endometrial, peritoneal and fallopian tube cancers.) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CA-125-Ag01 | Equine CA-125 | $3090.00 |
GMP-EQU-CA-125-Ab01 | Anti-Equine CA-125 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA-125-Ab02 | Anti-Equine CA-125 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA-125-Ab03 | Anti-Equine CA-125 human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CA-125-Ab04 | Anti-Equine CA-125 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-CA-125-Ag01 |
Product Name | Equine CA-125 |
Target/Biomarker | Equine CA-125 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine CA-125 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA-125 level test of animal Equine/Horse with ovarian, endometrial, peritoneal and fallopian tube cancers.. |
Tag | His | Reconized/Reactive Specics | Equine CA-125 |
Product description | Recombinant Equine CA-125 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CA-125-Ab01,GMP-EQU-CA-125-Ab02 |
Target/Biomarker | Equine CA-125 |
Product Name | Anti-Equine CA-125 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine CA-125 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA-125 antibodies in Equine CA-125 level test of animal Equine/Horse with ovarian, endometrial, peritoneal and fallopian tube cancers.. |
Product description | Anti-Equine CA-125 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA-125 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CA-125-Ab03,GMP-EQU-CA-125-Ab04 |
Target/Biomarker | Equine CA-125 |
Product Name | Anti-Equine CA-125 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine CA-125 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CA-125 antibodies in Equine CA-125 level test of animal Equine/Horse with ovarian, endometrial, peritoneal and fallopian tube cancers.. |
Product description | Anti-Equine CA-125 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Equine CA-125, an intriguing glycoprotein biomarker, stands as a distinctive feature in the realm of equine health. Its nomenclature draws parallels to mucin proteins, renowned for their intricate glycosylation patterns and diverse functions. In the equine physiology, CA-125 predominantly manifests within epithelial tissues, particularly within the reproductive and abdominal domains.
The structural complexity of Equine CA-125 hints at its multifaceted roles. Research has pointed towards its potential involvement in cellular adhesion, immune modulation, and signaling pathways. Its expression within the reproductive system underscores its potential relevance to fertility, embryo implantation, and overall reproductive health in horses.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.